Е. С. Герштейн

757 total citations
107 papers, 596 citations indexed

About

Е. С. Герштейн is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Е. С. Герштейн has authored 107 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 44 papers in Molecular Biology and 33 papers in Cancer Research. Recurrent topics in Е. С. Герштейн's work include Protease and Inhibitor Mechanisms (21 papers), Estrogen and related hormone effects (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Е. С. Герштейн is often cited by papers focused on Protease and Inhibitor Mechanisms (21 papers), Estrogen and related hormone effects (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Е. С. Герштейн collaborates with scholars based in Russia, United Kingdom and United States. Е. С. Герштейн's co-authors include Н. Е. Кушлинский, Krasil'nikov Ma, Е. А. Короткова, Alexander M. Scherbakov, И. С. Стилиди, В. Б. Матвеев, А. И. Щеголев, Alexei Morozov, В. Д. Ермилова and Victor Adler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and European Journal of Cancer.

In The Last Decade

Е. С. Герштейн

99 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Е. С. Герштейн Russia 14 263 256 201 120 64 107 596
Stephanie Petrillo Canada 18 394 1.5× 293 1.1× 216 1.1× 118 1.0× 94 1.5× 38 794
Sam D. Molyneux Canada 9 433 1.6× 209 0.8× 205 1.0× 106 0.9× 80 1.3× 11 710
Yifan Yang China 14 265 1.0× 154 0.6× 199 1.0× 100 0.8× 32 0.5× 71 535
Sabrina Danilin France 12 479 1.8× 175 0.7× 164 0.8× 136 1.1× 92 1.4× 24 640
Andreas Varkaris United States 17 393 1.5× 331 1.3× 253 1.3× 327 2.7× 55 0.9× 46 836
Amanda Mikels‐Vigdal United States 10 254 1.0× 206 0.8× 174 0.9× 140 1.2× 104 1.6× 14 662
Ji Hyun Lee South Korea 12 282 1.1× 269 1.1× 80 0.4× 232 1.9× 71 1.1× 23 609
Ida Katrine Lund Denmark 18 335 1.3× 264 1.0× 356 1.8× 90 0.8× 132 2.1× 43 839
Giuseppe Gullo Ireland 13 271 1.0× 368 1.4× 154 0.8× 151 1.3× 41 0.6× 42 692
M. Bianchi Italy 12 330 1.3× 191 0.7× 105 0.5× 115 1.0× 40 0.6× 43 704

Countries citing papers authored by Е. С. Герштейн

Since Specialization
Citations

This map shows the geographic impact of Е. С. Герштейн's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Е. С. Герштейн with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Е. С. Герштейн more than expected).

Fields of papers citing papers by Е. С. Герштейн

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Е. С. Герштейн. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Е. С. Герштейн. The network helps show where Е. С. Герштейн may publish in the future.

Co-authorship network of co-authors of Е. С. Герштейн

This figure shows the co-authorship network connecting the top 25 collaborators of Е. С. Герштейн. A scholar is included among the top collaborators of Е. С. Герштейн based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Е. С. Герштейн. Е. С. Герштейн is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Короткова, Е. А., et al.. (2023). Galectin-3 and matrix metalloproteinases 2 and 9 in peripheral blood of gastric cancer patients. SHILAP Revista de lepidopterología. 51(1). 23–31. 1 indexed citations
3.
Кушлинский, Н. Е., О. В. Ковалева, Vladimir Jurišić, et al.. (2023). Galectin-3 in the blood serum of patients with bone tumors. SHILAP Revista de lepidopterología. 22(2). 68–77.
4.
Герштейн, Е. С., et al.. (2022). Soluble forms of PD-1/PD-L immune checkpoint receptor and ligand in blood serum of breast cancer patients: association with clinical pathologic factors and molecular type of the tumor. Russian Clinical Laboratory Diagnostics. 67(2). 76–80. 2 indexed citations
5.
Nikonov, E.L., et al.. (2022). Zonulin is a marker of epithelial and endothelial barrier functions in non-communicable diseases (narrative review). Russian Journal of Evidence-Based Gastroenterology. 11(1). 28–28. 6 indexed citations
6.
7.
Кушлинский, Н. Е., et al.. (2021). Prognostic significance of soluble forms of immune checkpoint PD-1/PDL1 receptor and ligand in blood plasma of gastric cancer patients. Russian Clinical Laboratory Diagnostics. 66(3). 139–146. 6 indexed citations
8.
Герштейн, Е. С., et al.. (2021). Prognostic significance of the TNM system criteria, levels of serum insulin-like growth factors and their transport proteins, VEGF and MMP-7 in colorectal cancer. Russian Clinical Laboratory Diagnostics. 66(8). 459–464. 2 indexed citations
9.
Герштейн, Е. С., et al.. (2021). Prognostic significance of VEGF signaling system components and matrix metalloproteinases in blood serum of gastric cancer patients. Russian Clinical Laboratory Diagnostics. 66(11). 650–654. 1 indexed citations
10.
Кушлинский, Н. Е., О. В. Ковалева, Е. А. Короткова, et al.. (2021). Clinical and prognostic significance of the soluble form of the VISTA immunity control point in patients with primary bone tumors. Russian Clinical Laboratory Diagnostics. 66(9). 533–538. 3 indexed citations
11.
Герштейн, Е. С., et al.. (2020). Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients. SHILAP Revista de lepidopterología. 16(4). 39–47. 1 indexed citations
12.
13.
Герштейн, Е. С., et al.. (2020). SOLUBLE FORMS OF PD-1 AND PD-L1 IN BLOOD PLASMA OF GASTRIC CANCER PATIENTS AND THEIR ASSOCIATIONS WITH CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF THE DISEASE. Russian Clinical Laboratory Diagnostics. 65(6). 347–352. 6 indexed citations
14.
15.
Кушлинский, Н. Е., et al.. (2019). Soluble forms of the immune check-point receptor PD-1 and its ligand PD-L1 in blood serum of patients with renal cell carcinoma: clinical and pathologic correlations. SHILAP Revista de lepidopterología. 15(1). 15–22. 7 indexed citations
16.
Кушлинский, Н. Е., et al.. (2019). Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer. Bulletin of Experimental Biology and Medicine. 166(3). 373–376. 8 indexed citations
17.
Кушлинский, Н. Е., et al.. (2018). Modern approaches to kidney cancer immunotherapy. Cancer Urology. 14(2). 54–67. 13 indexed citations
18.
Герштейн, Е. С. & Н. Е. Кушлинский. (2015). Clinical prospects of IGF-signaling system components study in ovarian cancer patients. Drug Metabolism and Personalized Therapy. 30(2). 75–85. 4 indexed citations
19.
Герштейн, Е. С., et al.. (2011). Relationship between the Expression of VEGF Signal Components and Matrix Metalloproteinases in Ovarian Tumors. Bulletin of Experimental Biology and Medicine. 151(4). 449–453. 6 indexed citations
20.
Кушлинский, Н. Е., et al.. (2001). Plasminogen Activators and Their Inhibitor in Bone Tumors and Tumor-Like Damages. Bulletin of Experimental Biology and Medicine. 132(2). 780–782. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie Petrillo Breakdown of academic impact, for papers by Sam D. Molyneux Breakdown of academic impact, for papers by Yifan Yang Breakdown of academic impact, for papers by Sabrina Danilin Breakdown of academic impact, for papers by Andreas Varkaris Breakdown of academic impact, for papers by Amanda Mikels‐Vigdal Breakdown of academic impact, for papers by Ji Hyun Lee Breakdown of academic impact, for papers by Ida Katrine Lund Breakdown of academic impact, for papers by Giuseppe Gullo Breakdown of academic impact, for papers by M. Bianchi
Rankless by CCL
2026